ADAPX INC

Profile

Company Names

ADAPX INC

Addresses

2200 ALASKAN WAY, SUITE 130, SEATTLE, WA 98121

2127 FIFTH AVENUE, SEATTLE, WA 98121-2510

821 SECOND AVENUE, SUITE 1150, SEATTLE, WA 98104-1527

Phone Numbers

(206) 428-0800

 

Entity Type:

CORPORATION

Industry:

OTHER, OTHER TECHNOLOGY

Year Incorporated:

2007

State Incorporated:

DE

Total Amount Raised:

$28,248,611.00

Number of Funding Rounds:

8
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
8
2014-02-26 
$1,872,630.00 
$4,902,631.00 
$3,030,001.00 
Equity 
7
2014-01-17 
$299,999.00 
$1,000,000.00 
$700,001.00 
Debt 
6
2013-03-27 
$3,999,999.00 
$4,000,000.00 
$1.00 
Debt 
5
2012-07-13 
$3,000,000.00 
$3,500,000.00 
$500,000.00 
Debt 
4
2012-01-09 
$3,000,000.00 
$3,500,000.00 
$500,000.00 
Debt 
3
2011-01-05 
$1,999,897.00 
$2,000,000.00 
$103.00 
 
2
2009-05-19 
$18,666.00 
$18,666.00 
$0.00 
 
1
2009-04-13 
$14,057,420.00 
$14,228,080.00 
$170,660.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
PETER 
W. 
CHIARELLI 
DIRECTOR
ADAPX INC
PHILIP 
 
COHEN 
EXECUTIVE OFFICER, DIRECTOR
ADAPX INC
PHILLIP 
 
COHEN 
EXECUTIVE OFFICER, DIRECTOR
ADAPX INC
JAMES 
 
DREYFOUS 
DIRECTOR
ADAPX INC   |  VENAFI, INC   |  BLOXR CORP
MARK 
 
MALONEY 
DIRECTOR
ADAPX INC
DAVID 
 
MCGEE 
EXECUTIVE OFFICER
ADAPX INC
KENNETH 
 
SCHNEIDER 
EXECUTIVE OFFICER, DIRECTOR
ADAPX INC   |  BLUEFLAG SECURITY INC.
MARK 
 
SHAPLAND 
EXECUTIVE OFFICER
ADAPX INC
CHAD 
 
WAITE 
DIRECTOR
PLECTIX BIOSYSTEMS INC   |  ADAPX INC   |  XORI CORP   |  LIMERICK BIOPHARMA INC   |  VERDEZYNE INC   |  MIRINA CORP   |  ACYLIN THERAPEUTICS, INC.   |  ONCOFACTOR CORP   |  GROOVE BIOPHARMA CORP   |  AGGREGATE KNOWLEDGE INC   |  SYMFORM, INC.   |  CYRUS BIOTECHNOLOGY, INC.   |  TWINSTRAND BIOSCIENCES, INC.
CHARLES 
 
WAITE 
DIRECTOR
NANOSTRING TECHNOLOGIES INC   |  ADAPX INC
CHRIS 
 
WEBER 
DIRECTOR
ADAPX INC
CHRIS 
P. 
WEBER 
DIRECTOR
ADAPX INC
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2014-03-04
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2014-02-26 
2014-01-22
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Debt 
2014-01-17 
2013-12-03
D/A
Link
OTHER 
 
DECLINE TO DISCLOSE 
Debt 
2013-03-27 
2013-04-10
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Debt 
2013-03-27 
2012-07-30
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Debt 
2012-07-13 
2012-01-24
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Debt 
2012-01-09 
2011-05-20
D/A
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2009-04-13 
2011-01-12
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
 
2011-01-05 
2009-05-27
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
 
2009-05-19 
2009-04-13
D
Link
OTHER 
 
DECLINE TO DISCLOSE 
Equity 
2009-04-13 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#